Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Elderly

NCT01013675 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

622

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza Vaccines

Interventions

BIOLOGICAL: Influenza Vaccine
BIOLOGICAL: Influenza Vaccine

Sponsor

Abbott Biologicals

Collaborators

[object Object]